Categorie
Apo-Nitrofurantoin
Les marques,
Apo-Nitrofurantoin
Analogs
Apo-Nitrofurantoin
Les marques melange
No information avaliable
Apo-Nitrofurantoin
Formule chimique
C8H6N4O5
Apo-Nitrofurantoin
RX lien
http://www.rxlist.com/cgi/generic/nitro25m.htm
Apo-Nitrofurantoin
FDA fiche
Apo-Nitrofurantoin
msds (fiche de securite des materiaux)
Apo-Nitrofurantoin
Synthese de reference
Aucune information disponible
Apo-Nitrofurantoin
Poids moleculaire
238.157 g/mol
Apo-Nitrofurantoin
Point de fusion
263 oC
Apo-Nitrofurantoin
H2O Solubilite
79,5 mg / L
Apo-Nitrofurantoin
Etat
Solid
Apo-Nitrofurantoin
LogP
-0.04
Apo-Nitrofurantoin
Formes pharmaceutiques
Tablet
Apo-Nitrofurantoin
Indication
Pour le traitement de l'infection des voies urinaires
Apo-Nitrofurantoin
Pharmacologie
Nitrofurantoin, un nitrofurane agent antibactérien, est disponible sous forme microcristalline et macrocristallin pour traiter les infections des voies urinaires causées par de nombreuses bactéries gram-négatives et certaines bactéries Gram-positives.
Apo-Nitrofurantoin
Absorption
Aucune information disponible
Apo-Nitrofurantoin
Toxicite
Aucune information disponible
Apo-Nitrofurantoin
Information pour les patients
Patients should be advised to take Macrobid with food (ideally breakfast and dinner) to further
enhance tolerance and improve drug absorption. Patients should be instructed to complete the full course of therapy;
however, they should be advised to contact their physician if any unusual symptoms occur during therapy.
Patients should be advised not to use antacid preparations containing magnesium trisilicate while
taking Macrobid.
Patients should be counseled that antibacterial drugs including Macrobid should only be used to
treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Macrobid is
prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in
the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full
course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that
bacteria will develop resistance and will not be treatable by Macrobid or other antibacterial drugs in the
future.
Apo-Nitrofurantoin
Organismes affectes
Gram négatif et certaines bactéries Gram positives